2022 Q4 Form 20-F Financial Statement

#000117891323001195 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $74.08M $293.4M $76.64M
YoY Change -3.34% 2.42% 10.99%
Cost Of Revenue $13.92M $53.88M $14.05M
YoY Change -0.93% 2.74% 15.24%
Gross Profit $60.17M $239.5M $62.59M
YoY Change -3.88% 2.35% 10.08%
Gross Profit Margin 81.21% 81.64% 81.67%
Selling, General & Admin $41.97M $154.4M $37.83M
YoY Change 10.93% 9.85% 7.45%
% of Gross Profit 69.76% 64.44% 60.44%
Research & Development $22.49M $86.56M $19.60M
YoY Change 14.74% 16.82% 10.41%
% of Gross Profit 37.37% 36.14% 31.31%
Depreciation & Amortization $2.878M $11.69M $2.484M
YoY Change 15.86% 14.67% -7.31%
% of Gross Profit 4.78% 4.88% 3.97%
Operating Expenses $64.46M $240.9M $57.43M
YoY Change 12.23% 12.26% 8.44%
Operating Profit -$4.289M -$1.378M $5.164M
YoY Change -183.06% -107.09% 32.41%
Interest Expense $2.018M $8.052M -$463.0K
YoY Change -535.85% 93.14% -218.72%
% of Operating Profit -8.97%
Other Income/Expense, Net $8.052M
YoY Change 3283.19%
Pretax Income -$3.090M $4.713M $4.405M
YoY Change -170.15% -79.18% 2.68%
Income Tax $1.034M $4.879M $9.996M
% Of Pretax Income 103.52% 226.92%
Net Earnings -$4.124M -$166.0K -$5.591M
YoY Change -26.24% -102.13% -299.68%
Net Earnings / Revenue -5.57% -0.06% -7.29%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.09 $0.00 -$121.5K
COMMON SHARES
Basic Shares Outstanding 44.31M shares 44.94M shares
Diluted Shares Outstanding 44.94M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $298.0M $298.0M $287.9M
YoY Change 3.53% 3.53% -7.28%
Cash & Equivalents $46.19M $46.19M $92.51M
Short-Term Investments $251.9M $251.9M $195.4M
Other Short-Term Assets $7.196M -$4.232M $8.046M
YoY Change -10.56% -152.6% 23.78%
Inventory $11.43M $11.43M $11.58M
Prepaid Expenses
Receivables $17.75M $17.75M $13.19M
Other Receivables $8.646M $8.646M $0.00
Total Short-Term Assets $335.9M $335.9M $320.7M
YoY Change 4.73% 4.73% -7.79%
LONG-TERM ASSETS
Property, Plant & Equipment $44.15M $44.15M $45.07M
YoY Change -2.05% -2.05% -11.28%
Goodwill $68.01M $41.14M
YoY Change 65.29%
Intangibles $19.69M $10.73M
YoY Change 83.45%
Long-Term Investments $133.9M $133.9M $177.9M
YoY Change -24.74% -24.74% 28.66%
Other Assets $45.78M $45.78M $39.79M
YoY Change 15.06% 15.06% 21.68%
Total Long-Term Assets $311.5M $311.5M $314.7M
YoY Change -0.99% -0.99% 14.22%
TOTAL ASSETS
Total Short-Term Assets $335.9M $335.9M $320.7M
Total Long-Term Assets $311.5M $311.5M $314.7M
Total Assets $647.4M $647.4M $635.4M
YoY Change 1.89% 1.89% 1.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.067M $8.067M $4.310M
YoY Change 87.17% 87.17% 10.51%
Accrued Expenses $4.685M $4.685M $5.090M
YoY Change -7.96% -86.75% -75.41%
Deferred Revenue $108.2M $99.92M
YoY Change 8.33%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $166.4M $166.4M $165.9M
YoY Change 0.33% 0.33% 15.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $112.5M $112.5M $99.49M
YoY Change 13.1% 13.1% 9.21%
Total Long-Term Liabilities $112.5M $112.5M $99.49M
YoY Change 13.1% 13.1% 9.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $166.4M $166.4M $165.9M
Total Long-Term Liabilities $112.5M $112.5M $99.49M
Total Liabilities $315.2M $315.2M $265.4M
YoY Change 18.79% 18.79% 13.02%
SHAREHOLDERS EQUITY
Retained Earnings $141.4M $141.6M
YoY Change -0.12%
Common Stock $498.9M $471.9M
YoY Change 5.72%
Preferred Stock
YoY Change
Treasury Stock (at cost) $303.3M $243.0M
YoY Change 24.8%
Treasury Stock Shares 17.04M shares 14.77M shares
Shareholders Equity $332.2M $332.2M $370.0M
YoY Change
Total Liabilities & Shareholders Equity $647.4M $647.4M $635.4M
YoY Change 1.89% 1.89% 1.94%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$4.124M -$166.0K -$5.591M
YoY Change -26.24% -102.13% -299.68%
Depreciation, Depletion And Amortization $2.878M $11.69M $2.484M
YoY Change 15.86% 14.67% -7.31%
Cash From Operating Activities $9.560M $32.15M $28.93M
YoY Change -66.96% -55.21% 59.5%
INVESTING ACTIVITIES
Capital Expenditures $1.768M $38.81M -$1.653M
YoY Change -206.96% -792.74% -18.97%
Acquisitions $30.00M
YoY Change
Other Investing Activities $7.393M -$17.20M $16.65M
YoY Change -55.59% -227.89% -399.42%
Cash From Investing Activities $5.625M -$56.02M $15.00M
YoY Change -62.49% -813.7% -297.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$11.47M -$22.46M -$14.62M
YoY Change -21.56% -46.38% 586.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.47M -22.46M -14.62M
YoY Change -21.56% -46.38% 248.95%
NET CHANGE
Cash From Operating Activities 9.560M 32.15M 28.93M
Cash From Investing Activities 5.625M -56.02M 15.00M
Cash From Financing Activities -11.47M -22.46M -14.62M
Net Change In Cash 3.716M -46.33M 29.31M
YoY Change -87.32% -222.75% 362.27%
FREE CASH FLOW
Cash From Operating Activities $9.560M $32.15M $28.93M
Capital Expenditures $1.768M $38.81M -$1.653M
Free Cash Flow $7.792M -$6.666M $30.59M
YoY Change -74.53% -108.61% 51.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-30324
CY2022 dei Entity Registrant Name
EntityRegistrantName
RADWARE LTD.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L3
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
22 Raoul Wallenberg Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Tel Aviv
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
6971917
CY2022 dei Entity Address Country
EntityAddressCountry
IL
CY2022 dei Security12b Title
Security12bTitle
Ordinary Shares,NIS 0.05 par value per share
CY2022 dei Trading Symbol
TradingSymbol
RDWR
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44306891 shares
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
1281
CY2022 dei Auditor Name
AuditorName
KOST FORER GABBAY & KASIERER
CY2022 dei Auditor Location
AuditorLocation
Tel-Aviv, Israel
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
174000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
17039009 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
14769090 shares
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1986000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3466000 usd
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
333000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
18069000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates:</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></span></div> </div>
CY2022 rdwr Standard Warranty Term
StandardWarrantyTerm
P1Y
CY2022 us-gaap Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
<div> <div style="line-height:1.25"> </div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:56.7pt"> </td> <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.</span></span></td> <td style="width:auto;vertical-align:top;text-align:justify"> <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative and hedging activities:</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's risk management strategy includes the use of derivative financial instruments to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASC 815, "Derivatives and Hedging" ("ASC 815"), requires the Company to recognize all of its derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, an entity must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85pt;line-height:1.25;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gains and losses on derivatives instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that are attributable to a particular risk), are recorded in accumulated other comprehensive income (loss) and reclassified into consolidated statements of income (loss) in the same accounting period in which the designated forecasted transaction or hedged item affects earnings.</span></span></div> <div style="text-align:justify;margin-left:85pt;line-height:1.25;margin-bottom:0pt"> </div> <div/> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2022 and 2020, the Company entered into forward contracts to hedge a portion of anticipated New Israeli Shekel ("NIS") payroll and benefit payment. These derivative instruments are designated as cash flow hedges, as defined by ASC 815 and accordingly are measured in fair value. These transactions are effective and, as a result, gain or loss on the derivative instruments are reported as a component of accumulated other comprehensive income (loss) and reclassified as payroll expenses at the time that the hedged income or expense is recorded.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022, we had outstanding currency forwards contracts in the total amount of approximately $62,200 to hedge portions of our forecasted expenses denominated in NIS. These forwards contracts expire on various dates until September 30, 2023.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022, the Company recorded a liability in other payables and accrued expenses on its consolidated balance sheet in the amount of $632. The Company did not hold any outstanding forward contracts as of December 31, 2021.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 2022, 2021 and 2020, the Company recorded expenses of $318, nil and $79, respectively, in cost of revenues and $2,477, nil and $1,043, in operating expenses, respectively, related to its hedging forward contracts.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company currently hedges its exposure to the variability in future cash flows for a maximum period of one year. As of December 31, 2022, the Company expects to reclassify all of its unrealized losses from accumulated other comprehensive loss to earnings during the next twelve months.</span></span></div> </div>
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
632000 usd
CY2022Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
4663000 usd
CY2021Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
4752000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4057000 usd
CY2022Q4 rdwr Percentage Of Revenue
PercentageOfRevenue
1 pure
CY2022 rdwr Annual Interest Rate Of Royalties
AnnualInterestRateOfRoyalties
0.03 pure
CY2022 us-gaap Payments For Royalties
PaymentsForRoyalties
333000 usd
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
4258000 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
11170000 usd
CY2022Q4 rdwr Rightofuse Assets
RightofuseAssets
2289000 usd
CY2021Q4 rdwr Rightofuse Assets
RightofuseAssets
2372000 usd
CY2022 rdwr Recognition Deferred Tax Rate
RecognitionDeferredTaxRate
0.34 pure
CY2022 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
1698000 usd
CY2022 rdwr Income Tax Reconciliation Tax Benefit Related To Company Benefits
IncomeTaxReconciliationTaxBenefitRelatedToCompanyBenefits
-1457000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
476000 usd
CY2022 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
2327000 usd
CY2021 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
3100000 usd
CY2020 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
3177000 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
745000 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
5255000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1968000 usd
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
8018000 usd
CY2021 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6757000 usd
CY2020 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5201000 usd

Files In Submission

Name View Source Status
0001178913-23-001195-index-headers.html Edgar Link pending
0001178913-23-001195-index.html Edgar Link pending
0001178913-23-001195.txt Edgar Link pending
0001178913-23-001195-xbrl.zip Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_12-2.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
exhibit_13-2.htm Edgar Link pending
exhibit_15-1.htm Edgar Link pending
exhibit_8-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image1.jpg Edgar Link pending
image2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
rdwr-20221231_def.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
rdwr-20221231.xsd Edgar Link pending
rdwr_img01.jpg Edgar Link pending
rdwr_img02.jpg Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk2329425.htm Edgar Link pending
rdwr-20221231_cal.xml Edgar Link unprocessable
rdwr-20221231_lab.xml Edgar Link unprocessable
rdwr-20221231_pre.xml Edgar Link unprocessable
zk2329425_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable